The localization of the two type 1 angiotensin II receptor subtype (AT 1A and AT 1B ) messenger RNAs in the 19-day-old rat fetus was studied by in situ hybridization. AT! receptor mRNAs were detected in target organs of the reninangiotensin system such as the kidney, adrenal gland, liver, heart, large arteries, and pituitary gland. In addition, angiotensin II receptors were present in specialized mesenchymal cells surrounding the cartilage, in the pericardium, in the lung, and in the undifferentiated mesenchymal tissue. The AT 1A subtype was predominant in all tissues and organs except the adrenal cortex and glomeruli in the kidney, which expressed both AT 1A and AT 1B mRNAs. The widespread distribution of AT, receptors in tissues and organs involved in hydromineral equilibrium and blood pressure regulation shows that during fetal development angiotensin II may already act as a regulator of the cardiovascular system. An effect on cellular differentiation and/or proliferation via AT, receptors is also suggested by their location in several mesenchymes. 8 particularly in the undifferentiated mesenchymes under the skin, around skeletal muscles and cartilage, and within the tongue. Differentiated tissues and organs such as skeletal muscles, retina, adrenal gland, choroid plexus, liver, lung, and kidney were also positive for radiolabeled Ang II. However, the use of nonpeptide antagonists (losartan and PD123177) that distinguish between the two known types of Ang II receptors, type 1 (AT,) and type 2 (AT 2 ), 9 -10 has shown that most of these binding sites in the rat fetus are of the AT 2 type.
T he octapeptide angiotensin II (Ang II) exerts many physiological actions in the cardiovascular, endocrine, and central and peripheral nervous systems. Ang II maintains circulatory homeostasis by various mechanisms including vasoconstriction, stimulation of mineralocorticoid secretion in adrenal glands, and regulation of renal sodium transport. Moreover, depending on the experimental conditions, Ang II may have a hypertrophic effect on its target cells, such as murine mesangial cells 1 and rat vascular smooth muscle cells in culture, 2 or it could be mitogenic as in fetal mesangial cells, which have intrinsically different growth properties. 3 Recent experiments have also shown that Ang II could be mitogenic in the absence of growth factors. 4 Autoradiographic studies have shown a high transient expression of Ang II receptors in mouse, 5 rat, 6 ' 7 and primate fetuses, 8 particularly in the undifferentiated mesenchymes under the skin, around skeletal muscles and cartilage, and within the tongue. Differentiated tissues and organs such as skeletal muscles, retina, adrenal gland, choroid plexus, liver, lung, and kidney were also positive for radiolabeled Ang II. However, the use of nonpeptide antagonists (losartan and PD123177) that distinguish between the two known types of Ang II receptors, type 1 (AT,) and type 2 (AT 2 ), 9 -10 has shown that most of these binding sites in the rat fetus are of the AT 2 type. 11 A physiological function for the AT 2 receptor is unknown, but its abundance in the fetus has led to hypotheses about its role in fetal growth and differentiation. 11 Because of the large excess of AT 2 over AT, receptors in fetal tissues and the lack of cellular reso- lution, autoradiographic binding studies have not allowed a precise localization of the AT, receptor. This receptor type mediates all the known effects of Ang II on water and salt homeostasis and blood pressure.
A cDNA encoding an AT, receptor has been cloned and sequenced from rat aortic cells. 12 More recently, another cDNA has been cloned and sequenced from rat adrenal glomerulosa tissue. 13 Both of these cDNAs have a high degree of nucleotidic sequence identity in the coding region (91%) and a lower identity in the 5' and 3' noncoding regions (approximately 60%). These receptor subtypes are commonly referred to as AT, A and AT, B , respectively. To date, few pharmacologic differences have been reported between these two subtypes. 13 However, their differential tissue distribution and their differences in the 5' regulatory regions point to probable functional specificities. In the present study, in situ hybridization with cRNA probes prepared from AT, A and AT, B cDNAs was used to describe the tissue location of the two AT, receptor subtype mRNAs in the 19-day-old rat fetus. This methodology detects even a low level of AT, receptor mRNA with a resolution at the cellular level and without interference of massive amounts of AT 2 present in the same tissues.
The widespread distribution of the AT, receptor mRNA in previously known and unknown target tissues for Ang II lends support to an early role of this peptide hormone as a regulator of the cardiovascular system and also possibly as a growth factor during fetal development.
14 The comparison at the cellular level of AT 1A and AT, B distribution may help to clarify further the regulation and biologic functions of these two receptor subtypes. paraffin according to our routine procedure. Transverse and sagittal 5-jan sections were cut and mounted on 3-aminopropyltriethoxysilane (Aldrich Chemical Co)-coated glass slides. All animal procedures were performed in accordance with administrative guidelines. The clone pCal8b containing a 2.3-kb cDNA of the rat AT W receptor (a gift from Dr K. Bernstein) was digested with Hin&lll and Not I, and the insert was subcloned in the HindlU and Not I site of an expression vector derived from pECE 15 by insertion of unique BstXI, Nru I, and Not I restriction sites into the polylinker. 4 This construction was subsequently digested by Xba I, and the insert was subcloned in the unique Xba I site of the Bluescript KS plasmid (Stratagene, La Jolla, Calif). The Bluescript plasmid was used to synthesize the riboprobes. The cDNA was linearized by BamHI, a restriction site found in the multiple cloning site upstream to the T3 promoter of the plasmid, or Hpa I, a restriction site in the 5' region of the cDNA at position 131.
u Transcription in vitro was performed in the presence of 35 S-UTP (Amersham, Les Ulis, France) by T7 or T3 RNA polymerase (Boehringer, Mannheim, Germany) to synthesize the sense or antisense riboprobe, respectively.
A pCDNA II plasmid (Invitrogen, Oxon, UK) containing a 2.2-kb cDNA of the rat AT 1B receptor (clone RAG6D4.60, a gift from Dr K. Sandberg) was used to prepare the AT 1B riboprobe. The cDNA was linearized by Xba I, a restriction site located just upstream to the T7 promoter of the pCDNA II plasmid, and transcribed in vitro by Sp6 in the presence of •"S-UTP to synthesize an antisense probe.
The AT W and AT 1B cRNA probes should correspond to the full-length cDNAs and include the coding and noncoding sequences of the cDNAs. However, the length of the probe was verified on a 0.8% agarose gel (Fig 1) , which showed a band at 2 kb preceded by a smear extending toward smaller molecular weights. This smear corresponds to short transcripts, which are the product of an incomplete transcription.
The in situ hybridization was performed according to Sibony et al. 16 The sections were deparaffinized, dehydrated, and fixed with 4% paraformaldehyde and then treated with proteinase K, postfixed in 4% paraformaldehyde, and acetylated. Each section received 30 /iL of the hybridization mixture (50% fonmamide, 2x SSC [lx SSC: 0.15 mol/L sodium chloride and 0.015 mol/L sodium citrate], 70 mmol/L dithiothreitol, 1 mg/mL salmon sperm DNA, and 10% dextran sulfate) containing approximately 0.5 xlO" 6 cpm of sense or antisense probe. Hybridization was carried out overnight (16 hours) at 50°C. Then the slides were washed in the following solutions: 5x SSC, 10 mmol/L dithiothreitol at room temperature (30 minutes), and a second bath with the same solution at 50°C (30 minutes); 2x SSC, 50% formamide, 10 mmol/L dithiothreitol at 55°C (30 minutes); NaCl TE (0.5 mol/L NaCl, 10 mmol/L Tris-HCL at pH 7.6, and 5 mmol/L EDTA) at 37°C (10 minutes twice); RNAse A (20 Aig/mL) in 0.5 mol/L NaCl TE at 37°C (20 minutes); NaCl TE at 37°C (90 minutes); and 0.1 x SSC at room temperature (15 minutes). Slides were then dehydrated with increasing concentrations of ethanol, airdried, and dipped in liquid emulsion (NTB2, International Biotechnologies, Inc, New Haven, Conn). At the end of the exposure time (8 weeks) the slides were photographically processed and counterstained with toluidine blue.
Results
A clear hybridization signal was observed with the antisense probes in tissues and organs known to be the target sites of Ang II in the regulation of cardiovascular homeostasis (adrenal gland, kidney, liver, large arteries, and heart) and also in other sites not directly related to the pressor effects of Ang II, such as mesenchymes, the pituitary gland, and the lung. On adjacent sections, with the sense probe, no signal was observed except for a weak uniform background labeling.
In the kidney, labeled mesenchymal cells were observed in the cortex, associated with glomeruli at different maturation stages. In the S-shaped body of the newly forming glomerulus, the mesenchymal cells that invade the immature Bowman's capsule, probably contributing to the formation of the glomerular mesangium, showed a significant signal with both AT\ A and AT [B probes. In more mature glomeruli, mesangial cells were labeled (Fig 2A and 2B) , whereas the outer and inner epithelial layers of the Bowman's capsule were devoid of receptor mRNAs. The hybridization signal was slightly higher, and the number of positive cells within glomeruli was also greater with AT 1A (Fig 2A) than with AT 1B (Fig 2B) . In addition, ATi A was found in the glomeruli and other nephrogenic mesenchymal and epithelial tissues, whereas the AT 1B mRNA was strictly limited to the mesangial cells within the glomeruli. In the medulla, labeled cells aligned along the epithelial tubular structures and formed figures that evoked the future vasa recta associated in vascular bundles.
In the adrenal gland, the zona glomerulosa expressed higher levels of ATi receptor mRNAs compared with the zona fasciculata and adrenal medulla. ATi A mRNA showed a clear signal in the zona glomerulosa and the capsule (Fig 2C) , with low-level labeling in the inner layers of the cortex. AT 1B mRNA was strictly localized to the zona glomerulosa and absent in the capsule ( Fig  2D) . The cells in the adrenal medulla were positive with the AT 1A probe but not the AT 1B .
In the cardiac muscle, both the atria and ventricles expressed the AT, receptor mRNA diffusely (Fig 2E) , producing a signal significantly above the background observed with the sense probe (Fig 2F) . The hybridization signal was particularly visible in the atrioventricular septum, the interventricular septum, and the bundle of His. The pericardium and adventitia of the root of the aortic artery were strongly positive, in contrast to the cardiac valves and coronary arteries, which showed only a minimal labeling compared with the surrounding myocardium. The only AT, receptor mRNA subtype found in the heart was AT 1A .
In the liver, the predominant subtype was AT, A mRNA (Fig 3A) , whereas AT, B showed a weak labeling attributable to background (Fig 3B) . In the liver, three different subpopulations of cells could be distinguished by the intensity of labeling with the AT 1A probe ( Fig  3A) . A small minority of cells, with little cytoplasm and pale stained nuclei and generally isolated or in small groups not exceeding two or three cells, were intensely labeled. The absence of cytological features does not allow the identification of these cells. Another subpopulation, representing more than half the cells in the liver, displayed a moderate level of labeling. These cells were identified as being hepatocytes by their large, round nuclei with dispersed granulated chromatin. A third population composed of clusters of cells with small, dark nuclei had a minimal level of labeling, corresponding to background. They probably belong to the erythroblastic lineage.
In the lung, the alveolar epithelial lining showed very low labeling, whereas clusters of cells within mesenchymal tissue between the alveoli were rich in AT 1A mRNA (Fig 3C) . AT 1B mRNA was absent in the lung.
Large arteries in the fetus, especially the aorta and the pulmonary and cerebral arteries, expressed AT 1A mRNA in the tunica media and tunica adventitia ( Fig  3D) and were devoid of AT 1B mRNA. In addition, AT 1A mRNA but not AT lB was detected in the pituitary gland (Fig 3E and 3F) , perichondrium, adipose tissue, and smooth muscle of the esophagus but not that of the intestine and in specialized mesenchymes in different parts of the fetus.
Discussion
The present in situ hybridization study localized AT, receptor mRNAs in several organs of the 19-day-old rat fetus such as the adrenal gland, kidney, liver, heart, and large arteries, which have regulatory functions on blood pressure in the adult animal. Other sites not apparently linked to the pressor effect of Ang II have also been identified: pituitary gland, lung, and specialized mesenchymes (subepidermal layers and perichondrium). Previous binding studies on tissue sections, evaluated after autoradiographic exposure, had shown the presence of large amounts of Ang II binding sites in the 19-day-old rat ferus. 57 However, with the use of nonpeptidic antagonists, these receptors had been characterized as belonging to type 2, whose functions remain speculative. 11 We now describe the cellular localization of the two AT! receptor subtypes in the 19-day-old rat fetus and demonstrate that they are expressed with a tissue distribution partially overlapping that of AT 2 binding sites.
In the adult rat, the presence of AT 1A 1718 and AT 1B mRNAs 13 has been shown in various organs by Northern blot or polymerase chain reaction. However, these studies could not identify the type of cells expressing one or the other or both AT, receptor subtypes. By in situ hybridization with the same AT 1A cRNA probe used in the present work, we showed the expression of this AT, receptor mRNA in mesangial and juxtaglomerular cells. 19 In the fetus and neonate, a recent study reported the presence of AT, receptor mRNAs in the rat kidney and liver during the perinatal period.
14 Because it is not known whether the probes used in that study were strictly specific for AT 1A or were cross-hybridized with AT 1B mRNA, the signal obtained could be attributed to either one or both receptor subtype mRNAs. Our study demonstrates the existence of three different types of distribution: almost similar levels of AT 1A and AT 1B mRNAs (glomeruli of the kidney), the predominance of AT 1B (zona glomerulosa of the adrenal gland), or the exclusive presence of AT U (lung, liver, and the pituitary gland). Although the two cDNAs from which our cRNA probes were transcribed share a high degree of homology in the coding regions, there appears to be very limited cross-hybridization under our experimental conditions. This is shown by the differential distribution of AT 1A and AT 1B mRNAs in the kidney (Fig 2A and 2B) , adrenal gland (Fig 2C and 2D) , liver (Fig 3A and 3B) , and pituitary gland (Fig 3E and 3F) . The specificity of the two riboprobes can be explained by the fact that although they are obtained after transcription of the entire cDNA, they contain a large proportion of short transcripts as shown by the presence of a smear in the autoradiography of the gel (Fig 1) . These short transcripts corresponding to the 3' noncoding regions lie close to the initiation site of transcription and show an identity of less than 62%, 13 insufficient for cross-hybridization under our conditions. This is also confirmed in CHO cells transfected with the AT 1A cDNA, which displayed only a low-level signal when hybridized with the AT 1B probe, although they express AT 1A mRNA at a rate far greater than normal Ang II target cells in the animal (unpublished observations).
The presence of AT, A and ATi B mRNAs in the 19-day-old fetus suggests that Ang II plays an important role in the regulation of blood pressure during fetal development. The widespread distribution of AT 1A mRNA in organs and tissues such as the adrenal gland, kidney, liver, heart, lung, and pituitary gland and in the differentiating mesenchymes suggests that this receptor subtype may be predominant in mediating the effects of Ang II in the rat fetus. The restricted distribution in the fetus of AT 1B mRNA to the zona glomerulosa of the adrenal gland and kidney suggests that Ang II may be involved in water and salt homeostasis through the AT 1B receptor subtype. AT 1A might rather act as a mediator of growth and/or differentiation in tissues, such as the lung, heart, and mesenchymes, although more specific functions, such as the feedback control of angiotensinogen expression in the liver, are also probable.
Interestingly, AT 1A mRNA is abundant in the pituitary gland of the fetus, whereas this organ is known to be rich in AT 1B mRNA in the adult rat. 13 This demonstrates a change in the expression of the specific AT! receptor subtype occurring after birth. Thus, our study of the two subtypes of the Ang II receptors in the 19-day-old rat fetus demonstrates the differential prenatal and postnatal expression and regulation of these receptors. The cause of this differential level of mRNA of the two receptor subtypes can be attributed not only to the dissimilarity of the nucleotidic sequence between the two mRNAs but also to other developmentally regulated cytoplasmic or nuclear transcriptional factors. The specific pattern of spatiotemporal expression of the two Ang II receptor subtypes in the fetus and adult rat may be the basis of functional specificities that remain to be elucidated.
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